We are live on ! Find out more
CIS

Capital International Sarl Portfolio holdings

AUM $6.11B
1-Year Est. Return 32.29%
This Fund
S&P 500
This Quarter Est. Return
+26.76%
1 Year Est. Return
+32.29%
3 Year Est. Return
+120.6%
5 Year Est. Return
+165.23%
10 Year Est. Return
+684.77%
AUM
$752M
AUM Growth
+$203M
Cap. Flow
+$69.1M
Cap. Flow %
9.19%
Top 10 Hldgs %
24.27%
Holding
249
New
20
Increased
142
Reduced
34
Closed
44

Top Buys

Rank Stock Value
1
LEGN icon
Legend Biotech
LEGN
+$12.3M
2
BAP icon
Credicorp
BAP
+$6.47M
3
MRK icon
Merck
MRK
+$5.41M
4
AME icon
Ametek
AME
+$4.68M
5
TRP icon
TC Energy
TRP
+$4.32M

Sector Composition

Rank Sector Weight
1 Technology 20.58%
2 Healthcare 20.01%
3 Financials 14.67%
4 Communication Services 9.71%
5 Consumer Discretionary 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVGO icon
1
Broadcom
AVGO
$1.81T
$21.5M 2.86%
681,370
+54,880
+9% +$1.54M
MSFT icon
2
Microsoft
MSFT
$2.89T
$20.9M 2.78%
102,806
-1,295
-1% -$235K
ONC
3
BeOne Medicines Ltd
ONC
$34B
$19.6M 2.61%
104,287
+1,011
+1% +$165K
AMZN icon
4
Amazon
AMZN
$2.47T
$19.1M 2.54%
138,200
+19,040
+16% +$2.3M
TSM icon
5
TSMC
TSM
$2.01T
$19M 2.53%
335,233
+61,784
+23% +$3.26M
V icon
6
Visa
V
$701B
$18.5M 2.46%
95,667
+9,149
+11% +$1.67M
HCM icon
7
HUTCHMED
HCM
$1.95B
$16.5M 2.2%
599,528
-47,264
-7% -$1.03M
NBIS
8
Nebius Group N.V.
NBIS
$40.6B
$16.3M 2.16%
325,251
+55,800
+21% +$2.23M
SGEN
9
DELISTED
Seagen Inc. Common Stock
SGEN
$15.6M 2.07%
91,662
+5,019
+6% +$749K
AAPL icon
10
Apple
AAPL
$5.03T
$15.4M 2.05%
169,336
+37,088
+28% +$2.87M
LEGN icon
11
Legend Biotech
LEGN
$3.72B
$13.4M 1.79%
+315,510
New +$12.3M
PM icon
12
Philip Morris
PM
$313B
$13.2M 1.76%
188,513
+42,397
+29% +$3.09M
JPM icon
13
JPMorgan Chase
JPM
$939B
$12.1M 1.61%
128,980
+42,404
+49% +$4.02M
AMT icon
14
American Tower
AMT
$82B
$11.8M 1.56%
45,489
-3,570
-7% -$883K
ABT icon
15
Abbott
ABT
$189B
$11.7M 1.56%
128,284
+15,143
+13% +$1.37M
INTC icon
16
Intel
INTC
$440B
$11.7M 1.56%
195,591
+2,537
+1% +$152K
ATVI
17
DELISTED
Activision Blizzard
ATVI
$11.5M 1.53%
151,198
-682
-0.4% -$47.6K
AMX icon
18
America Movil
AMX
$75.9B
$11.4M 1.52%
899,142
+110,125
+14% +$1.38M
B
19
Barrick Mining
B
$60.4B
$11.4M 1.52%
422,922
-45,595
-10% -$1.14M
GDDY icon
20
GoDaddy
GDDY
$13.7B
$11M 1.47%
150,333
+22,391
+18% +$1.61M
CVX icon
21
Chevron
CVX
$382B
$10.1M 1.34%
113,036
+12,036
+12% +$1.08M
CCI icon
22
Crown Castle
CCI
$33.6B
$9.99M 1.33%
59,709
+2,611
+5% +$421K
MCO icon
23
Moody's
MCO
$84B
$9.88M 1.31%
35,954
+3,670
+11% +$932K
UNH icon
24
UnitedHealth
UNH
$388B
$9.78M 1.3%
33,148
+7,171
+28% +$2.05M
META icon
25
Meta Platforms (Facebook)
META
$1.5T
$9.28M 1.23%
40,882
+4,700
+13% +$981K

Similar funds

Capital International Sarl's Q2 2020 Portfolio in Review

As of Q2 2020, Capital International Sarl held 249 positions worth $752M, up 37% from $549M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Capital International Sarl deployed $69.1M of net new capital in Q2 2020, opening 20 new positions and adding to 142 existing holdings. Its largest new stake was Legend Biotech: 315,510 shares worth $13.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Enbridge, an estimated $4.04M trimmed.

  • Capital International Sarl's largest Q2 2020 buy was Legend Biotech: 315,510 shares worth $13.4M.
  • Capital International Sarl added most to Merck in Q2 2020, an estimated $5.41M increase.
  • Capital International Sarl's biggest Q2 2020 reduction was Enbridge, cutting an estimated $4.04M.
  • Capital International Sarl fully exited Alibaba in Q2 2020, selling an estimated $16M.
  • Capital International Sarl's ten largest holdings make up 24% of its $752M portfolio in Q2 2020.
  • Capital International Sarl opened 20 new positions and closed 44 in Q2 2020.
  • Capital International Sarl's portfolio value rose 37% quarter-over-quarter to $752M.

Based on Capital International Sarl's 13F filing for Q2 2020, filed 14 Aug 2020.